Cryosite Ltd FY2026 Results: Revenue Up 18%, EBITDA Up 27%
Key points
- FY2026 revenue up 18% to $16.7m
- EBITDA up 27% to $4.3m
- EBITDA margin increased by 1.8 percentage points
- Strong client pipeline for FY2027
- Expansion projects progressing well
Full summary
Cryosite Ltd (ASX: CTE) reported its unaudited financial results for the twelve months to 30 June 2026. The company closed FY2026 with revenue up 18% to $16.7 million and EBITDA up 27% to $4.3 million. EBITDA margin increased by 1.8 percentage points to 25.7%. Earnings grew faster than revenue, driven by higher capacity utilization and margin expansion. The fourth quarter maintained momentum, with June revenue of $1.5 million and EBITDA of $0.4 million. With the Ferndell Street cool room expansion complete and the Adderley Street facility progressing, Cryosite's focus for FY2027 is to convert additional capacity into client activity. The client pipeline is strong, and the company looks forward to updating shareholders as the year progresses.
Guidance
FY2026 revenue up 18%, EBITDA up 27%, EBITDA margin increased by 1.8 percentage points
Outlook
Cryosite's focus for FY2027 is to convert additional capacity into client activity, with a strong client pipeline.
Summary generated by a large language model. Please interpret with care.